title: [Impact of surgery for residual tumors after chemotherapy].
abstract: Metastases are a feature not only of local tumor manifestation but also of systemic disease. Thus, the question arises regarding the extent to which local therapy contributes to a systemic state of disease. With renal cell carcinoma, resection of pulmonary metastases is a common operation. Other sites should be considered individually. Only a well-defined subset of patients with metastasized urothelial carcinoma benefit from the resection of their metastases.
authors.affiliation: Klinik und Poliklinik für Urologie, Hufelandstrasse 55, 45122 Essen.
authors.forename: J
authors.initials: J
authors.lastname: Hess
authors.forename: F
authors.initials: F
authors.lastname: vom Dorp
authors.forename: M
authors.initials: M
authors.lastname: Becker
authors.forename: H
authors.initials: H
authors.lastname: Rübben
authors.forename: C
authors.initials: C
authors.lastname: Börgermann
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D014571:Urologic Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D013520:Urologic Surgical Procedures / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents